SEMPREX - acrivastine and pseudoephedrine hydrochloride
Navigation: NDC > Supplier starting with: A > ACTIENT PHARMACEUTICALS, LLC| Field | Value |
|---|---|
| NDC Code: | 52244-404 |
| Proprietary Name: | SEMPREX |
| Suffix: | D |
| Non-Proprietary Name: | acrivastine and pseudoephedrine hydrochloride |
| Dosage Form: | CAPSULE |
| Method: | ORAL |
| Original Marketing Date: | 26-01-2012 |
| Category Name: | NDA |
| Application Number: | NDA019806 |
| Labeler: | ACTIENT PHARMACEUTICALS, LLC |
| Substance Name: | ACRIVASTINE; PSEUDOEPHEDRINE HYDROCHLORIDE |
| Active Numerator Strength: | 8; 60 |
| Active Ingredient Unit: | mg/1; mg/1 |
| Pharm Classes: | Histamine H1 Receptor Antagonists [MoA],Histamine-1 Receptor Antagonist [EPC],Adrenergic alpha-Agonists [MoA],alpha-Adrenergic Agonist [EPC] |
| DEA Schedule: |